|
Cardiovascular disease (CVD) is the greatest threat to women's health worldwide, and the leading cause of death for women in the US. It affects more women than men, it kills more than 420,000 women annually and nearly 43 million American women live with some form of CVD. According to the U.S. Census Bureau, Texas has the third highest prevalence of heart disease in women—affecting more than 600,000 in 2004. CVD, also known as heart and vascular disease, includes heart attack, heart failure, stroke, peripheral artery disease and other diseases of the heart and circulatory system.
Most American women are unaware of their risk. Most doctors are too.
Women can expect to live a large part of their lives with an increased risk of CVD because their risk increases four-fold at menopause. One out of four American women older than 65 has some form of heart disease. Because heart attack symptoms can be very different in women than in men, women and the doctors who treat them are often unaware that a heart attack has occurred. Since treatment during or immediately after a heart attack significantly mitigates the resulting long-term damage, accurately identifying symptoms of heart attacks is critical to the lifetime wellness of women.
Just as symptoms differ between men and women, so may the effectiveness of treatments. Treatment guidelines are developed from the results of clinical trials published in the medical literature, dictating the standard of care for all patients. However, less than 25% of those enrolled in these trials are women. While effective treatments are not fully understood, we do know that women have 50% more adverse reactions to drugs than men, that controlling women's blood pressure reduces their risk more dramatically than men and that depression has double the negative impact on women than on men. What's more, the trajectory of women's heart disease is distinct from that of men. For example, plaque builds up differently in women's arteries, which typical testing does not detect. Finally, little study has gone into effective prevention strategies for women. The goal of this symposium is to educate primary care physicians and cardiologists about diagnosis, treatment and prevention of heart disease in women.
Target Audience
Cardiologists, gynecologists, primary care physicians, Internal medicine physicians, family practice practitioners, endocrinologists and nurse practitioners.
Learning Objectives
At the conclusion of this conference, the participant should be able to:
- Cite the identification of cardiac risk factors in women;
- Describe the trends and treatments of cardiovascular disease in obesity and sedentary lifestyles;
- Review current guidelines for calcium supplementation and calcium scoring by computed tomography;
- Identify emerging controversies in cardiovascular disease and treatments;
- Make an overall cardiovascular risk stratification of female patients that will be used to guide prevention and treatment strategies.
Program Schedule
Saturday October 1, 2011
8:30 - 9:00 a.m. Registration and Breakfast
8:45 - 9:00 Welcome and Opening Remarks
James T. Willerson, MD
President and Medical Director
THI at SLEH
9:00 - 9:20 Epidemiology of Coronary Artery Disease
and Cardiac Risk Factor
Stephanie Coulter, MD
Director, Center for Women's Heart &
Vascular Health
THI at SLEH
9:20 - 9:40 Hypertension: Prevalence in Racial Groups,
Women's Increased Risks
Addison Taylor, MD, PhD
Professor of Medicine
Baylor College of Medicine
9:40 - 10:00 Dyslipidemia: Importance of Non HDL
Cholesterol in 2011
Salim Virani, MD
Assistant Professor
Baylor College of Medicine
10:00 - 10:20 Discussion
10:20 - 10:40 Break
10:40 - 11:00 Obesity and Sedentary Lifestyles Related to
Cardiovascular Disease in Women
Ann Barnes, MD
Assistant Professor of Medicine
Baylor College of Medicine
11:00 - 11:20 Diabetes and Cardiovascular Disease:
What Have We Learned?
David Aguilar, MD
Assistant Professor of Medicine
Baylor College of Medicine
11:20 - 11:40 Depression and Coronary Heart Disease
Roberta C. Bogaev, MD, FACC, FACP
Medical Director, Heart Failure & Transplant
THI at SLEH
11:40 - Noon Discussion
Noon - 1:00 p.m. Lunch 1:00 -2:00 p.m. Ethics Lecture: Inclusion of Women in
Cardiovascular Research and its
Importance for Women's Health
Anne Hamilton Dougherty, MD, FACC,
FHRS, FAHA
Professor of Medicine,
Director, Cardiac Electrophysiology
Co-Director, Advanced Cardiac
Arrhythmia Center
Vice President, Human Research
The University of Texas Health Science
Center-Houston
2:00 - 2:20 Post-Menopausal Hormone Therapy
Stephanie Coulter, MD
2:20 - 2:40 Cardiac Diseas in Pregnancy
Wilson Lam, MD
Texas Children's Hospital & THI at SLEH
Combined Adult-Pediatric Cardiology Fellow
Baylor College of Medicine
2:40 - 3:00 Discussion
3:00 - 3:20 Break
3:20 - 3:40 Emerging Controversies in
Cardiovascular Disease and Treatments
Stephanie Coulter, MD
3:40 - 4:00 Coronary Revascularization in 2011
When should we do it and why?
Guilherme Silva, MD
Clinical Assistant Professor
Baylor College of Medicine
Assistant Medical Director, Stem Cell Center
THI at SLEH
4:00 - 4:20 TAVI: The Hype and the Hope
Blase Carabello, MD
Professor Medicine, Vice-Chairman,
Department of Medicine,
Baylor College of Medicine
Medical Care Line Executive,
Veterans Affairs Medical Center
Director, Center for Heart Valve Disease,
THI at SLEH
4:20 - 4:40 Discussion
4:40 Adjourn
See the program brochure for further details. |
Second Annual 
